Cargando…

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy

Detalles Bibliográficos
Autores principales:	Selim, Rania, Wellens, Judith, Brann, Stephanie, Marlow, Luke, Adams, Alex, Satsangi, Jack J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492423/ https://www.ncbi.nlm.nih.gov/pubmed/36152635 http://dx.doi.org/10.1016/S2468-1253(22)00302-8

Ejemplares similares

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021)

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022)

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
por: Brain, Oliver, et al.
Publicado: (2021)

1163: BOTH VEDOLIZUMAB AND ANTI-TNF THERAPY ARE ASSOCIATED WITH ATTENUATION OF SEROLOGICAL AND NEUTRALIZING RESPONSES TO SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE
por: Wellens, Judith, et al.
Publicado: (2022)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

Reply
por: Nowak, Jan Krzysztof, et al.
Publicado: (2021)

Ultra-processed foods as a possible culprit for the rising prevalence of inflammatory bowel diseases
por: Vissers, Eva, et al.
Publicado: (2022)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
por: Aldhous, Marian C., et al.
Publicado: (2009)

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
por: Barberio, Brigida, et al.
Publicado: (2021)

The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013)

Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
por: Wellens, Judith, et al.
Publicado: (2023)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Inflammatory bowel disease in Lebanon: a plea for help
por: Mourad, Fadi H, et al.
Publicado: (2022)

Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies
por: Corridoni, Daniele, et al.
Publicado: (2020)

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
por: Prentice, Ralley E., et al.
Publicado: (2020)

Adalimumab for treatment of very early onset inflammatory bowel disease
por: Xie, Yao, et al.
Publicado: (2019)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel Disease
por: Joustra, Vincent, et al.
Publicado: (2022)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease
por: Joustra, Vincent, et al.
Publicado: (2022)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Washed microbiota transplantation improves the fertility of patients with inflammatory bowel disease
por: Zhao, Zhaoyang, et al.
Publicado: (2022)

The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis
por: Aldana, Isabella, et al.
Publicado: (2022)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists
por: Cappello, Maria, et al.
Publicado: (2021)

Genetic evidence for the oral-gut axis between periodontitis and inflammatory bowel disease
por: Wang, Zhongyuan, et al.
Publicado: (2023)

Intravenous Pituitrin
por: Vasavada, D. M.
Publicado: (1925)

Intravenous Pituitrin
por: Row, Y. S.
Publicado: (1925)

Intravenous Iodine
por: Bouche, B. J.
Publicado: (1925)

Intravenous Iodine
por: Chaudhuri, J. C.
Publicado: (1925)

Intravenous Iodine
por: Jeudwine, W. W.
Publicado: (1924)

Cannot write session to /tmp/vufind_sessions/sess_o8lbqhr2nv0tmaoth844pb5pq6